• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    AnaptysBio, Inc. - Common Stock (NQ:ANAB)

    57.53 -0.34 (-0.59%)
    Streaming Delayed Price Updated: 10:38 AM EDT, Aug 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 56,589
    Open 57.99
    Bid (Size) 57.37 (400)
    Ask (Size) 57.82 (400)
    Prev. Close 57.87
    Today's Range 56.86 - 58.11
    52wk Range 11.40 - 72.36
    Shares Outstanding 27,433,359
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
    From Energy Metal News
    Via GlobeNewswire
    News headline image
    Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
    From AnaptysBio, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +92.0%
    +92.0%
    1 Month
    -17.6%
    -17.6%
    3 Month
    -12.3%
    -12.3%
    6 Month
    +71.8%
    +71.8%
    1 Year
    +331.5%
    +331.5%

    More News

    Read More
    News headline image
    Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
    From AnaptysBio, Inc.
    Via GlobeNewswire
    AnaptysBio (NASDAQ:ANAB) Passes Minervini Trend Template and High Growth Momentum Screen ↗
    Via Chartmill
    ANAPTYBIO INC (NASDAQ:ANAB) Offers High-Growth Momentum and a Bullish Technical Setup ↗
    Via Chartmill
    ANAPTYSBIO INC (NASDAQ:ANAB) Shows Minervini Trend Template and High-Growth Momentum Alignment ↗
    Via Chartmill
    ANAB Stock Falls After It Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal ↗
    Via Stocktwits
    Topics Lawsuit
    News headline image
    Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
    From AnaptysBio, Inc.
    Via GlobeNewswire
    Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
    Via Chartmill
    What's going on in today's session ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
    From AnaptysBio, Inc.
    Via GlobeNewswire
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    Anaptys Announces Participation at Upcoming Investor Conferences
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    What Investors Should Know About a $163K AnaptysBio Insider Sale ↗
    Via The Motley Fool
    Topics Intellectual Property Regulatory Compliance
    News headline image
    Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    AnaptysBio Inc (NASDAQ:ANAB) Meets Minervini Trend Template with High-Growth Momentum ↗
    Via Chartmill
    News headline image
    Anaptys Announces Participation in December Investor Conferences
    From AnaptysBio, Inc.
    Via GlobeNewswire
    News headline image
    AnaptysBio Inc (NASDAQ:ANAB) Screens as a High-Growth Momentum Leader ↗
    Via Chartmill

    Frequently Asked Questions

    Is AnaptysBio, Inc. - Common Stock publicly traded?
    Yes, AnaptysBio, Inc. - Common Stock is publicly traded.
    What exchange does AnaptysBio, Inc. - Common Stock trade on?
    AnaptysBio, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for AnaptysBio, Inc. - Common Stock?
    The ticker symbol for AnaptysBio, Inc. - Common Stock is ANAB on the Nasdaq Stock Market
    What is the current price of AnaptysBio, Inc. - Common Stock?
    The current price of AnaptysBio, Inc. - Common Stock is 57.53
    When was AnaptysBio, Inc. - Common Stock last traded?
    The last trade of AnaptysBio, Inc. - Common Stock was at 08/12/26 10:38 AM ET
    What is the market capitalization of AnaptysBio, Inc. - Common Stock?
    The market capitalization of AnaptysBio, Inc. - Common Stock is 1.58B
    How many shares of AnaptysBio, Inc. - Common Stock are outstanding?
    AnaptysBio, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.